PYMNTS.com March 18, 2025

Generative artificial intelligence (GenAI) is rapidly transitioning from a futuristic concept to a tangible force reshaping the healthcare landscape.

Buoyed by early successes, healthcare firms are aggressively increasing their investments in GenAI, particularly in areas like product innovation and customer service, signaling a shift in how the industry operates.

A report from PYMNTS Intelligence, “Healthcare Firms Going Long on GenAI Investment,” reveals that these bets are already yielding significant returns, prompting a wave of further adoption among major players.

The report surveyed C-suite executives at healthcare firms with at least $1 billion in annual revenue to understand their GenAI strategies.

The findings indicate a strong conviction in the technology’s potential, with nine in 10 executives anticipating a positive return on...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Health System / Hospital, Provider, Survey / Study, Technology, Trends
DispatchHealth, Medically Home Merger Creates Comprehensive High-Acuity Care Platform
Hospitals with highest, lowest heart failure readmission rates
The effects of funding cuts on academic medical centers: 7 notes
California hospital reopens after 2-year closure
‘Innovation through collaboration’: New chief’s game plan for cardiac surgery at University Hospitals

Share This Article